Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes.

No Thumbnail Available
Authors
Myngheer, N.
Allegaert, K.
Hattersley, Andrew T.
McDonald, Timothy J.
Kramer, H.
Ashcroft, F. M.
Verhaeghe, J.
Mathieu, C.
Casteels, K.
Journal
Diabetes care
Type
Journal Article
Case Report
Research Support, Non-U.S. Gov't
Publisher
American Diabetes Association
Rights
Archived with thanks to Diabetes Care
Sulfonylureas (SUs) are effective at controlling glycemia in permanent neonatal diabetes mellitus (PNDM) caused by KCNJ11 (Kir6.2) mutations.
Citation
Fetal macrosomia and neonatal hyperinsulinemic hypoglycemia associated with transplacental transfer of sulfonylurea in a mother with KCNJ11-related neonatal diabetes. 2014, 37 (12):3333-5 Diabetes Care
Note